Author

Vasiliki Kotoula

Observed names: Kotoula Vasiliki, Kotoula, Vasiliki, V Kotoula, V. Kotoula, VASILIKI KOTOULA, Vasiliki Kotoula-Dimitriadou

Institution: Aristotle University of Thessaloniki

Observed institutions: Democritus University of Thrace, Victor Chang Cardiac Research Institute, Aristotle University of Thessaloniki, AHEPA University Hospital, Yale University, Papageorgiou General Hospital, Hellenic Cooperative Oncology Group, University General Hospital Attikon, Siemens Healthineers (Germany)

OpenAlex ID: A5113674763

Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes

2011 · Irene Bouchliou, Paraskevi Miltiades, et al. · Clinical Immunology · 49

Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer

2015 · Daniel E. Carvajal-Hausdorf, Kurt A. Schalper, et al. · JNCI Journal of the National Cancer Institute · 38

Prognostic and Predictive Role of Vascular Endothelial Growth Factor Polymorphisms in Breast Cancer

2015 · Angelos Koutras, Vasiliki Kotoula, et al. · Pharmacogenomics · 30

EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.

2010 · T Koletsa, V Kotoula, et al. · PubMed · 22

PDF

Intradural extramedullary Ewing's sarcoma: A case report and review of the literature

2016 · Konstantinos Paterakis, Alexandros Brotis, et al. · Neurologia i Neurochirurgia Polska · 20

Expression pattern of the Hedgehog signaling pathway in pituitary adenomas

2015 · Maria P. Yavropoulou, Anna Maladaki, et al. · Neuroscience Letters · 10

Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts

2016 · Dimitris I. Hatzibougias, Ioannis Fouzas, et al. · International Journal of Surgical Pathology · 5

Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer

2016 · DIMITRIOS PECTASIDES, VASILIKI KOTOULA, et al. · Anticancer Research · 3

PDF

mRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma

2020 · Spyridon Kampantais, Vasiliki Kotoula, et al. · Molecular and Clinical Oncology · 2

PDF

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer

2011 · George Fountzilas, D. Pectasides, et al. · Anticancer Research · 2

Prognostic significance of PI3K mRNA expression in patients with operable high-risk breast cancer

2009 · G. Papaxoinis, D. Pectasides, et al. · Journal of Clinical Oncology · 2

HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research

2026 · E. Fountzilas, K. Papadopoulou, et al. · ESMO Real World Data and Digital Oncology

Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma

2020 · Spyridon Kampantais, Ilias Kounatidis, et al. · The International Journal of Biological Markers

Tumor mutational patterns and infiltrating lymphocyte density in young and old patients with breast cancer

2019 · A. Nikolaidi, V. Kotoula, et al. · The Breast

Abstract P1-07-24: Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A hellenic cooperative oncology group (HeCOG) study

2018 · A Koutras, V Kotoula, et al. · Cancer Research

Intrinsic tumor features underlying clinical subtype discordance in early breast cancer

2017 · V. Kotoula, E. Giannoulatou, et al. · Annals of Oncology

PDF

Abstract P6-09-07: Mutation characteristics and tumor infiltrating lymphocytes in early and metastatic HER2-positive breast cancer

2017 · V Kotoula, E Giannoulatou, et al. · Cancer Research

Abstract P4-14-05: Genomic parameters affecting the outcome of patients with advanced breast cancer treated with trastuzumab

2016 · H Gogas, V Kotoula, et al. · Cancer Research

Abstract P2-07-02: Tumor infiltrating lymphocytes density and coding mutations effects on the outcome of operable triple negative breast cancer patients

2016 · V Kotoula, E Fountzilas, et al. · Cancer Research

Abstract P3-07-06: Objective measurement of HER2 (ERBB2) intracellular and extracellular domain spatial co-localization stratifies benefit from adjuvant trastuzumab

2016 · DE Carvajal-Hausdorf, M Toki, et al. · Cancer Research

Bilateral Breast Cancer

2016 · Fountzila, Elena, Fountzilas, George, et al. · Figshare

1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study

2015 · G. Papaxoinis, V. Kotoula, et al. · European Journal of Cancer

Insulin Growth Factor Receptor as a Prognostic Marker in Operable Squamous-Cell Laryngeal Cancer

2012 · G. Mountzios, I. Kostopoulos, et al. · Annals of Oncology

8742 POSTER Temozolomide and Lapatinib Combination in Patients With Recurrent High Grade Gliomas – a Phase I Study of the Hellenic Cooperative Oncology Group (HeCOG)

2011 · V. Karavasilis, G. Pentheroudakis, et al. · European Journal of Cancer

8504 ORAL Tumoural MRNa Profile of Angiogenesis/hypoxia Effectors in Patients With Operable Squamous Cancer of the Larynx

2011 · G. Pentheroudakis, V. Kotoula, et al. · European Journal of Cancer

Works count: 29

Citation count: 183

H-index: 6

I10-index: 6